Cargando…

Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China

BACKGROUND: COPD is the fourth leading cause of death worldwide, with particularly high rates in the People’s Republic of China, even among never smokers. Large population-based cohort studies should allow for reliable assessment of the determinants of diseases, which is dependent on the quality of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurmi, Om P, Vaucher, Julien, Xiao, Dan, Holmes, Michael V, Guo, Yu, Davis, Kourtney J, Wang, Chen, Qin, Haiyan, Turnbull, Iain, Peng, Peng, Bian, Zheng, Clarke, Robert, Li, Liming, Chen, Yiping, Chen, Zhengming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780206/
https://www.ncbi.nlm.nih.gov/pubmed/27042034
http://dx.doi.org/10.2147/COPD.S100736
_version_ 1782419740081258496
author Kurmi, Om P
Vaucher, Julien
Xiao, Dan
Holmes, Michael V
Guo, Yu
Davis, Kourtney J
Wang, Chen
Qin, Haiyan
Turnbull, Iain
Peng, Peng
Bian, Zheng
Clarke, Robert
Li, Liming
Chen, Yiping
Chen, Zhengming
author_facet Kurmi, Om P
Vaucher, Julien
Xiao, Dan
Holmes, Michael V
Guo, Yu
Davis, Kourtney J
Wang, Chen
Qin, Haiyan
Turnbull, Iain
Peng, Peng
Bian, Zheng
Clarke, Robert
Li, Liming
Chen, Yiping
Chen, Zhengming
author_sort Kurmi, Om P
collection PubMed
description BACKGROUND: COPD is the fourth leading cause of death worldwide, with particularly high rates in the People’s Republic of China, even among never smokers. Large population-based cohort studies should allow for reliable assessment of the determinants of diseases, which is dependent on the quality of disease diagnoses. We assessed the validity of COPD diagnoses collected through electronic health records in the People’s Republic of China. METHODS: The CKB study recruited 0.5 million adults aged 30–79 years from ten diverse regions in the People’s Republic of China during the period 2004–2008. During 7 years of follow-up, 11,800 COPD cases were identified by linkage with mortality registries and the national health insurance system. We randomly selected ~10% of the reported COPD cases and then undertook an independent adjudication of retrieved hospital medical records in 1,069 cases. RESULTS: Overall, these 1,069 cases were accrued over a 9-year period (2004–2013) involving 153 hospitals across ten regions. A diagnosis of COPD was confirmed in 911 (85%) cases, corresponding to a positive predictive value of 85% (95% confidence interval [CI]: 83%–87%), even though spirometry testing was not widely used (14%) in routine hospital care. The positive predictive value for COPD did not vary significantly by hospital ranking or calendar period, but was higher in men than women (89% vs 79%), at age ≥70 years than in younger people (88%, 95% CI: 85%–91%), and when the cases were reported from both death registry and health insurance systems (97%, 95% CI: 94%–100%). Among the remaining cases, 87 (8.1%) had other respiratory diseases (chiefly pneumonia and asthma; n=85) and 71 (6.6%) cases showed no evidence of any respiratory disease on their clinical records. CONCLUSION: In the People’s Republic of China, COPD diagnoses obtained from electronic health records are of good quality and suitable for large population-based studies and do not warrant systematic adjudication of all the reported cases.
format Online
Article
Text
id pubmed-4780206
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47802062016-04-01 Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China Kurmi, Om P Vaucher, Julien Xiao, Dan Holmes, Michael V Guo, Yu Davis, Kourtney J Wang, Chen Qin, Haiyan Turnbull, Iain Peng, Peng Bian, Zheng Clarke, Robert Li, Liming Chen, Yiping Chen, Zhengming Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: COPD is the fourth leading cause of death worldwide, with particularly high rates in the People’s Republic of China, even among never smokers. Large population-based cohort studies should allow for reliable assessment of the determinants of diseases, which is dependent on the quality of disease diagnoses. We assessed the validity of COPD diagnoses collected through electronic health records in the People’s Republic of China. METHODS: The CKB study recruited 0.5 million adults aged 30–79 years from ten diverse regions in the People’s Republic of China during the period 2004–2008. During 7 years of follow-up, 11,800 COPD cases were identified by linkage with mortality registries and the national health insurance system. We randomly selected ~10% of the reported COPD cases and then undertook an independent adjudication of retrieved hospital medical records in 1,069 cases. RESULTS: Overall, these 1,069 cases were accrued over a 9-year period (2004–2013) involving 153 hospitals across ten regions. A diagnosis of COPD was confirmed in 911 (85%) cases, corresponding to a positive predictive value of 85% (95% confidence interval [CI]: 83%–87%), even though spirometry testing was not widely used (14%) in routine hospital care. The positive predictive value for COPD did not vary significantly by hospital ranking or calendar period, but was higher in men than women (89% vs 79%), at age ≥70 years than in younger people (88%, 95% CI: 85%–91%), and when the cases were reported from both death registry and health insurance systems (97%, 95% CI: 94%–100%). Among the remaining cases, 87 (8.1%) had other respiratory diseases (chiefly pneumonia and asthma; n=85) and 71 (6.6%) cases showed no evidence of any respiratory disease on their clinical records. CONCLUSION: In the People’s Republic of China, COPD diagnoses obtained from electronic health records are of good quality and suitable for large population-based studies and do not warrant systematic adjudication of all the reported cases. Dove Medical Press 2016-03-01 /pmc/articles/PMC4780206/ /pubmed/27042034 http://dx.doi.org/10.2147/COPD.S100736 Text en © 2016 Kurmi et al. This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Research
Kurmi, Om P
Vaucher, Julien
Xiao, Dan
Holmes, Michael V
Guo, Yu
Davis, Kourtney J
Wang, Chen
Qin, Haiyan
Turnbull, Iain
Peng, Peng
Bian, Zheng
Clarke, Robert
Li, Liming
Chen, Yiping
Chen, Zhengming
Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China
title Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China
title_full Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China
title_fullStr Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China
title_full_unstemmed Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China
title_short Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China
title_sort validity of copd diagnoses reported through nationwide health insurance systems in the people’s republic of china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780206/
https://www.ncbi.nlm.nih.gov/pubmed/27042034
http://dx.doi.org/10.2147/COPD.S100736
work_keys_str_mv AT kurmiomp validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT vaucherjulien validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT xiaodan validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT holmesmichaelv validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT guoyu validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT daviskourtneyj validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT wangchen validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT qinhaiyan validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT turnbulliain validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT pengpeng validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT bianzheng validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT clarkerobert validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT liliming validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT chenyiping validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina
AT chenzhengming validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina